Literature DB >> 26605912

Multicentric Cancer Detected at Breast MR Imaging and Not at Mammography: Important or Not?

Chiara Iacconi1, Lanie Galman1, Junting Zheng1, Virgilio Sacchini1, Elizabeth J Sutton1, David Dershaw1, Elizabeth A Morris1.   

Abstract

PURPOSE: To review the magnetic resonance (MR) imaging and pathologic features of multicentric cancer detected only at MR imaging and to evaluate its potential biologic value.
MATERIALS AND METHODS: This retrospective study was institutional review board approved and HIPAA compliant; informed consent was waived. A review of records from 2001 to 2011 yielded 2021 patients with newly diagnosed breast cancer who underwent biopsy after preoperative MR imaging, 285 (14%) of whom had additional cancer detected at MR imaging that was occult at mammography. In 73 patients (3.6%), MR imaging identified 87 cancers in different quadrants than the known index cancer, constituting the basis of this report. In 62 of 73 patients (85%; 95% confidence interval [CI]: 75, 92), one additional cancer was found, and in 11 of 73 (15%; 95% CI: 8, 25), multiple additional cancers were found. A χ(2) test with adjustment for multiple lesions was used to examine whether MR imaging and pathologic features differ between the index lesion and additional multicentric lesions seen only at MR imaging.
RESULTS: Known index cancers were more likely to be invasive than MR imaging-detected multicentric cancers (88% vs 76%, P = .023). Ductal carcinoma in situ (21 of 87 lesions [24%]; 95% CI: 15, 36) represented a minority of additional MR imaging-detected multicentric cancers. Overall, the size of MR imaging-detected multicentric invasive cancers (median, 0.6 cm; range, 0.1-6.3 cm) was smaller than that of the index cancer (median, 1.2 cm; range, 0.05-7.0 cm; P = .023), although 17 of 73 (23%) (95% CI: 14, 35) patients had larger MR imaging-detected multicentric cancers than the known index lesion, and 18 of 73 (25%) (95% CI: 15, 36) had MR imaging-detected multicentric cancers larger than 1 cm. MR imaging-detected multicentric cancers and index cancers differed in histologic characteristics, invasiveness, and grade in 27 of 73 (37%) patients (95% CI: 26, 49). In four of 73 (5%) patients (95% CI: 2, 13), MR imaging-detected multicentric cancers were potentially more biologically relevant because of the presence of unsuspected invasion or a higher grade.
CONCLUSION: Multicentric cancer detected only at MR imaging was invasive in 66 of 87 patients (76%), larger than 1 cm in 18 of 73 patients (25%), larger than the known index cancer in 17 of 73 patients (23%), and more biologically important in four of 73 women (5%). An unsuspected additional multicentric cancer seen only at MR imaging is likely clinically relevant disease. (©) RSNA, 2015.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26605912      PMCID: PMC5015863          DOI: 10.1148/radiol.2015150796

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  18 in total

Review 1.  Breast MR imaging in assessing extent of disease.

Authors:  Laura Liberman
Journal:  Magn Reson Imaging Clin N Am       Date:  2006-08       Impact factor: 2.266

2.  Background parenchymal enhancement at breast MR imaging and breast cancer risk.

Authors:  Valencia King; Jennifer D Brooks; Jonine L Bernstein; Anne S Reiner; Malcolm C Pike; Elizabeth A Morris
Journal:  Radiology       Date:  2011-04-14       Impact factor: 11.105

3.  Preoperative breast MRI for early-stage breast cancer: effect on surgical and long-term outcomes.

Authors:  Janice S Sung; Jie Li; Glenys Da Costa; Sujata Patil; Kimberly J Van Zee; D David Dershaw; Elizabeth A Morris
Journal:  AJR Am J Roentgenol       Date:  2014-06       Impact factor: 3.959

4.  EUSOMA criteria for performing pre-operative MRI staging in candidates for breast conserving surgery: hype or helpful?

Authors:  Daniela Bernardi; Stefano Ciatto; Marco Pellegrini; Marvi Valentini; Nehmat Houssami
Journal:  Breast       Date:  2012-06       Impact factor: 4.380

5.  Screening breast MR imaging in women with a history of lobular carcinoma in situ.

Authors:  Janice S Sung; Sharp F Malak; Punam Bajaj; Rebecca Alis; D David Dershaw; Elizabeth A Morris
Journal:  Radiology       Date:  2011-09-07       Impact factor: 11.105

6.  American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer.

Authors:  Antonio C Wolff; M Elizabeth H Hammond; Jared N Schwartz; Karen L Hagerty; D Craig Allred; Richard J Cote; Mitchell Dowsett; Patrick L Fitzgibbons; Wedad M Hanna; Amy Langer; Lisa M McShane; Soonmyung Paik; Mark D Pegram; Edith A Perez; Michael F Press; Anthony Rhodes; Catharine Sturgeon; Sheila E Taube; Raymond Tubbs; Gail H Vance; Marc van de Vijver; Thomas M Wheeler; Daniel F Hayes
Journal:  J Clin Oncol       Date:  2006-12-11       Impact factor: 44.544

7.  Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up.

Authors:  C W Elston; I O Ellis
Journal:  Histopathology       Date:  1991-11       Impact factor: 5.087

8.  MRI evaluation of the contralateral breast in women with recently diagnosed breast cancer.

Authors:  Constance D Lehman; Constantine Gatsonis; Christiane K Kuhl; R Edward Hendrick; Etta D Pisano; Lucy Hanna; Sue Peacock; Stanley F Smazal; Daniel D Maki; Thomas B Julian; Elizabeth R DePeri; David A Bluemke; Mitchell D Schnall
Journal:  N Engl J Med       Date:  2007-03-28       Impact factor: 91.245

9.  MR imaging findings in the contralateral breast of women with recently diagnosed breast cancer.

Authors:  Laura Liberman; Elizabeth A Morris; Cathleen M Kim; Jennifer B Kaplan; Andrea F Abramson; Jennifer H Menell; Kimberly J Van Zee; D David Dershaw
Journal:  AJR Am J Roentgenol       Date:  2003-02       Impact factor: 3.959

10.  Fifteen-year results of breast-conserving surgery and definitive irradiation for Stage I and II breast carcinoma: the University of Pennsylvania experience.

Authors:  Roberto J Santiago; Leester Wu; Eleanor Harris; Kevin Fox; Delray Schultz; John Glick; Lawrence J Solin
Journal:  Int J Radiat Oncol Biol Phys       Date:  2004-01-01       Impact factor: 7.038

View more
  9 in total

1.  Factors associated with MRI detection of occult lesions in newly diagnosed breast cancers.

Authors:  Julie Wecsler; Young Ju Jeong; Akshara S Raghavendra; Wendy J Mack; Debasish Tripathy; Mary W Yamashita; Pulin A Sheth; Linda Hovanessian Larsen; Christy A Russell; Heather MacDonald; Stephen F Sener; Julie E Lang
Journal:  J Surg Oncol       Date:  2020-01-26       Impact factor: 3.454

2.  Diffusional kurtosis imaging for differentiation of additional suspicious lesions on preoperative breast MRI of patients with known breast cancer.

Authors:  Vivian Youngjean Park; Sungheon G Kim; Eun-Kyung Kim; Hee Jung Moon; Jung Hyun Yoon; Min Jung Kim
Journal:  Magn Reson Imaging       Date:  2019-07-16       Impact factor: 2.546

3.  Role of magnetic resonance imaging in the planning of breast cancer treatment strategies: comparison with conventional imaging techniques.

Authors:  Luciana Karla Lira França; Almir Galvão Vieira Bitencourt; Hugo Lamartine Souza Paiva; Caroline Baptista Silva; Nara Pacheco Pereira; Jociana Paludo; Luciana Graziano; Camila Souza Guatelli; Juliana Alves de Souza; Elvira Ferreira Marques
Journal:  Radiol Bras       Date:  2017 Mar-Apr

Review 4.  Imaging in Locoregional Management of Breast Cancer.

Authors:  Christiane K Kuhl; Constance Lehman; Isabelle Bedrosian
Journal:  J Clin Oncol       Date:  2020-05-22       Impact factor: 44.544

5.  Frequency and characteristics of contralateral breast abnormalities following recall at screening mammography.

Authors:  Joost R C Lameijer; Angela Mp Coolen; Adri C Voogd; Luc J Strobbe; Marieke W J Louwman; Dick Venderink; Vivian C Tjan-Heijnen; Lucien E M Duijm
Journal:  Eur Radiol       Date:  2018-04-17       Impact factor: 5.315

Review 6.  Breast Magnetic Resonance Imaging for Patients With Newly Diagnosed Breast Cancer: A Review.

Authors:  Soo-Yeon Kim; Nariya Cho
Journal:  J Breast Cancer       Date:  2022-08       Impact factor: 2.922

7.  The Usefulness of Spectral Mammography in Surgical Planning of Breast Cancer Treatment-Analysis of 999 Patients with Primary Operable Breast Cancer.

Authors:  Andrzej Lorek; Katarzyna Steinhof-Radwańska; Anna Barczyk-Gutkowska; Wojciech Zarębski; Piotr Paleń; Karol Szyluk; Joanna Lorek; Anna Grażyńska; Paweł Niemiec; Iwona Gisterek
Journal:  Curr Oncol       Date:  2021-07-12       Impact factor: 3.677

8.  Preclinical study of diagnostic performances of contrast-enhanced spectral mammography versus MRI for breast diseases in China.

Authors:  Qingguo Wang; Kangan Li; Lihui Wang; Jianbing Zhang; Zhiguo Zhou; Yan Feng
Journal:  Springerplus       Date:  2016-06-17

9.  International Consensus on the Clinical Management of Inflammatory Breast Cancer from the Morgan Welch Inflammatory Breast Cancer Research Program 10th Anniversary Conference.

Authors:  Naoto T Ueno; Jose Rodrigo Espinosa Fernandez; Massimo Cristofanilli; Beth Overmoyer; Dan Rea; Fedor Berdichevski; Mohamad El-Shinawi; Jennifer Bellon; Huong T Le-Petross; Anthony Lucci; Gildy Babiera; Sarah M DeSnyder; Mediget Teshome; Edward Chang; Bora Lim; Savitri Krishnamurthy; Michael C Stauder; Simrit Parmar; Mona M Mohamed; Angela Alexander; Vicente Valero; Wendy A Woodward
Journal:  J Cancer       Date:  2018-04-06       Impact factor: 4.207

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.